Comments
Drug firm Jubilant Life Sciences today said it has raised Rs 50 crore through issuing commercial papers.
“The company has issued commercial papers for an aggregate amount of Rs 50 crore on October 14, 2016, having maturity date of December 20, 2016,” Jubilant said in a BSE filing.
“The aggregate amount of commercial papers outstanding as on date is Rs 50 crore,” it said.
Jubilant stock closed at Rs 648.10 per scrip, up 0.79 per cent, on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.